Literature DB >> 26578531

Green tea consumption and glutathione S-transferases genetic polymorphisms on the risk of adult leukemia.

Ping Liu1, Min Zhang2,3, Xing Xie4, Jie Jin5, C D'Arcy J Holman2.   

Abstract

PURPOSE: Green tea may have a beneficial role of inhibiting leukemia. Glutathione S-transferases (GSTs) are known to detoxify certain carcinogens. We investigated the roles of green tea consumption and polymorphisms of GSTM1, GSTT1 and GSTP1 on the risk of adult leukemia, and to determine whether the associations varied within GSTs genotypes.
METHODS: A multicenter case-control study was conducted in China, 2008-2013. It comprised 442 incident, hematologically confirmed adult leukemia cases and 442 outpatient controls, individually matched to cases by gender, birth quinquennium and study site. Data were collected by face-to-face interview using a validated questionnaire. Genetic polymorphisms were assayed by PCR.
RESULTS: An inverse association between green tea consumption and adult leukemia risk was observed. Compared with non-tea drinkers, the adjusted odds ratios (95 % confidence intervals) were 0.50 (0.27-0.93), 0.31 (0.17-0.55) and 0.53 (0.29-0.99) for those who, respectively, consumed green tea >20 years, ≥2 cups daily and dried tea leaves >1000 g annually. In assessing the associations by GSTs genotypes, risk reduction associated with green tea consumption was stronger in individuals with the GSTT1-null genotype (OR 0.24; 95 % CI 0.11-0.53) than GSTT1-normal carriers (OR 0.67; 95 % CI 0.42-1.05; P interaction = 0.02). GSTM1 and GSTP1 did not significantly modify the inverse association of leukemia with green tea.
CONCLUSIONS: The results suggest that regular daily green tea consumption may reduce leukemia risk in Chinese adults regardless of GSTM1 and GSTP1 polymorphic status. The association between green tea and adult leukemia risk varied with GSTT1 genotype and highlights further study.

Entities:  

Keywords:  Adult leukemia; GST; Genetic polymorphism; Gene–diet interaction; Green tea

Mesh:

Substances:

Year:  2015        PMID: 26578531     DOI: 10.1007/s00394-015-1104-x

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  29 in total

1.  A quantitative food frequency questionnaire for women in southeast China: development and reproducibility.

Authors:  M Zhang; C W Binns; A H Lee
Journal:  Asia Pac J Public Health       Date:  2005       Impact factor: 1.399

2.  Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia.

Authors:  Hai-rong He; Xiao-xia Zhang; Jin-yue Sun; Sa-sa Hu; Ying Ma; Ya-lin Dong; Jun Lu
Journal:  Tumour Biol       Date:  2014-06

3.  Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.

Authors:  Silvia Funke; Maria Timofeeva; Angela Risch; Michael Hoffmeister; Christa Stegmaier; Christoph M Seiler; Hermann Brenner; Jenny Chang-Claude
Journal:  Pharmacogenomics       Date:  2010-01       Impact factor: 2.533

4.  Diet and risk of adult leukemia: a multicenter case-control study in China.

Authors:  Ping Liu; C D'Arcy J Holman; Jie Jin; Min Zhang
Journal:  Cancer Causes Control       Date:  2015-06-14       Impact factor: 2.506

5.  Glutathione S-transferase gene polymorphisms and susceptibility to acute myeloid leukemia: meta-analyses.

Authors:  Hai-Rong He; Hai-Sheng You; Jin-Yue Sun; Sa-Sa Hu; Ying Ma; Ya-Lin Dong; Jun Lu
Journal:  Jpn J Clin Oncol       Date:  2014-08-21       Impact factor: 3.019

6.  Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer.

Authors:  Matthew R Bonner; Nathaniel Rothman; Judy L Mumford; Xingzhou He; Min Shen; Robert Welch; Meredith Yeager; Stephen Chanock; Neil Caporaso; Qing Lan
Journal:  Mutat Res       Date:  2005-04-04       Impact factor: 2.433

7.  Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia.

Authors:  S Rollinson; P Roddam; E Kane; E Roman; R Cartwright; A Jack; G J Morgan
Journal:  Carcinogenesis       Date:  2000-01       Impact factor: 4.944

8.  Tea consumption and ovarian cancer risk: a case-control study in China.

Authors:  Min Zhang; Colin W Binns; Andy H Lee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-08       Impact factor: 4.254

9.  HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking.

Authors:  Junichiro Sonoda; Chihaya Koriyama; Shinako Yamamoto; Tomohiro Kozako; Hong Chuan Li; Carolina Lema; Shinji Yashiki; Toshinobu Fujiyoshi; Mitsuhiro Yoshinaga; Yukihiro Nagata; Suminori Akiba; Toshiro Takezaki; Katsushi Yamada; Shunro Sonoda
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

10.  VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.

Authors:  Yean K Lee; Nancy D Bone; Ann K Strege; Tait D Shanafelt; Diane F Jelinek; Neil E Kay
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

View more
  4 in total

Review 1.  A Review of Dietary (Phyto)Nutrients for Glutathione Support.

Authors:  Deanna M Minich; Benjamin I Brown
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

2.  Association Between the Individual and Combined Effects of the GSTM1 and GSTT1 Polymorphisms and Risk of Leukemia: A Meta-Analysis.

Authors:  Ting Hu; Guozhong Zhou; Wenjin Li
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

3.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02

Review 4.  Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.

Authors:  Yasuyoshi Miyata; Tomohiro Matsuo; Kyohei Araki; Yuichiro Nakamura; Yuji Sagara; Kojiro Ohba; Hideki Sakai
Journal:  Medicines (Basel)       Date:  2018-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.